Unknown NA INTERVENTIONAL 3-arm NCT03801135

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

A Prospective Interventional Study to Investigate Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation With or Without Coagulation Factors Replacement

Sponsor: University Medical Centre Ljubljana

Conditions CIDP Good Pasture Syndrome Guillain-Barre Syndrome Humoral Rejection Hyperviscosity Syndrome Miller Fisher Syndrome

Interventions Fibrinogen concentrate Fresh Frozen Plasma

Updated 5 times since 2019 Last updated: Jan 10, 2019 Started: Oct 3, 2018 Primary completion: Sep 1, 2019 Completion: Sep 24, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates CIDP and Good Pasture Syndrome and is currently ongoing. University Medical Centre Ljubljana leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Feb 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Centre Ljubljana

Data source: University Medical Centre Ljubljana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ljubljana, Slovenia